These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8850302)

  • 1. Kinetic studies of Helicobacter pylori urease inhibition by a novel proton pump inhibitor, rabeprazole.
    Park JB; Imamura L; Kobashi K
    Biol Pharm Bull; 1996 Feb; 19(2):182-7. PubMed ID: 8850302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori urease inhibition by rabeprazole, a proton pump inhibitor.
    Tsuchiya M; Imamura L; Park JB; Kobashi K
    Biol Pharm Bull; 1995 Aug; 18(8):1053-6. PubMed ID: 8535394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication.
    Sharara AI
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):863-70. PubMed ID: 16307499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory action of YJA20379, a new proton pump inhibitor on Helicobacter pylori growth and urease.
    Woo TW; Chang MS; Chung YK; Kim KB; Sohn SK; Kim SG; Choi WS
    Arch Pharm Res; 1998 Feb; 21(1):6-11. PubMed ID: 9875507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rabeprazole (E3810), a novel proton pump inhibitor, on intragastric pH in healthy volunteers.
    Hongo M; Kimpara T; Moriyama S; Ohara S; Sone S; Tamura T; Asaki S; Toyota T
    Tohoku J Exp Med; 1998 Sep; 186(1):43-50. PubMed ID: 9915106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
    Stack WA; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey CJ; Atherton JC
    Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells.
    Nagata K; Satoh H; Iwahi T; Shimoyama T; Tamura T
    Antimicrob Agents Chemother; 1993 Apr; 37(4):769-74. PubMed ID: 8494373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of an increased dosage regimen of rabeprazole versus a concomitant dosage regimen of famotidine with rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotypes.
    Sugimoto M; Furuta T; Shirai N; Nakamura A; Kajimura M; Hishida A; Ohashi K; Ishizaki T
    Clin Pharmacol Ther; 2005 Apr; 77(4):302-11. PubMed ID: 15903128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
    Li XQ; Andersson TB; Ahlström M; Weidolf L
    Drug Metab Dispos; 2004 Aug; 32(8):821-7. PubMed ID: 15258107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proton pump inhibitor, E3810, has antibacterial activity through binding to Helicobacter pylori.
    Hirai M; Azuma T; Ito S; Kato T; Kohli Y
    J Gastroenterol; 1995 Aug; 30(4):461-4. PubMed ID: 7550855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel action of the proton pump inhibitor rabeprazole and its thioether derivative against the motility of Helicobacter pylori.
    Tsutsui N; Taneike I; Ohara T; Goshi S; Kojio S; Iwakura N; Matsumaru H; Wakisaka-Saito N; Zhang HM; Yamamoto T
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3069-73. PubMed ID: 11036024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2C19 genotype and the PPIs--focus on rabeprazole.
    Lim PW; Goh KL; Wong BC
    J Gastroenterol Hepatol; 2005 Dec; 20 Suppl():S22-8. PubMed ID: 16359346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease.
    Nagata K; Takagi E; Tsuda M; Nakazawa T; Satoh H; Nakao M; Okamura H; Tamura T
    Antimicrob Agents Chemother; 1995 Feb; 39(2):567-70. PubMed ID: 7726537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients.
    Wong WM; Huang J; Xia HH; Fung FM; Tong TS; Cheung KL; Ho VY; Lai KC; Chan CK; Chan AO; Hui CK; Lam SK; Wong BC
    J Gastroenterol Hepatol; 2005 Jun; 20(6):935-40. PubMed ID: 15946144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition of Ureaplasma urealyticum by the proton pump inhibitor lansoprazole: direct attribution to inhibition by lansoprazole of urease activity and urea-induced ATP synthesis in U. urealyticum.
    Nagata K; Takagi E; Satoh H; Okamura H; Tamura T
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2187-92. PubMed ID: 8619564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent topics on important drugs for H. pylori eradication: Rabeprazole].
    Sugimoto M; Furuta T; Nakmura A; Shirai N
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():350-3. PubMed ID: 16363558
    [No Abstract]   [Full Text] [Related]  

  • 17. Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole.
    Horn J
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():11-9. PubMed ID: 15496214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabeprazole: an update of its use in acid-related disorders.
    Carswell CI; Goa KL
    Drugs; 2001; 61(15):2327-56. PubMed ID: 11772142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of proton pump inhibitors].
    Herszényi L; Tulassay Z
    Orv Hetil; 2001 Sep; 142(36):1953-61. PubMed ID: 11680100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Particular features of application of proton pump inhibitors (Rabeprazole) in children with the gastroesophageal reflux disease].
    Khavkin AI; Zhikhareva NS; Rachkova NS; Babaian ML; Volynets GV; Khanakaeva ZK
    Eksp Klin Gastroenterol; 2004; (2):53-6. PubMed ID: 15462323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.